Pharma
Trump Demands Drug Price Cuts in Letters to 17 Pharma Giants Summary
US President Donald Trump has sent letters to 17 major pharmaceutical companies demanding they cut prescription drug prices in the United States. The letters, released Thursday by the White...
Trump pressures 17 pharma CEOs to cut US drug prices
[WASHINGTON] President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the...
Trump orders up 50% tariff on copper, says levies on Big Pharma are coming
President Trump said Tuesday he would issue a 50% tariff on copper brought into the U.S. and signaled he was queuing up high levies on pharmaceutical imports after a...
Torrent to acquire KKR’s stake in JB Pharma for US$1.4 billion
[MUMBAI] Torrent Pharmaceuticals agreed to take a controlling stake in JB Chemicals & Pharmaceuticals from private equity firm KKR, the latest sign of a dealmaking boom in India.Torrent will...
Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Porton Advanced Solutions and EVA Pharma have signed a memorandum of understanding (MoU) to enhance the development and manufacturing capabilities for chimeric antigen receptor (CAR) T-cell therapies at the...
Europe’s Pharma Industry Braces for Pain as Trump Tariff Threat Looms
Insulin, heart treatments and antibiotics have flowed freely across many borders for decades, exempt from tariffs in a bid to make medicine affordable. But that could soon change.For months,...
Pharma boss says German plant closures ‘a disaster waiting to happen’
Christof Guenther, Managing Director of InfraLeuna GmbH, speaks at a press conference at the Leuna Chemical Park, following a fire that broke out this morning. The managing director of...
US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
[LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, boosting US prices by as much as 12.9 per...
Temasek-backed 65 Equity Partners makes Europe foray with Swiss pharma merger
[LONDON] Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis’ (HAS) acquisition of Cerbios-Pharma, marking its first deal in Europe.The investor, backed by Temasek,...
